Open Access iconOpen Access

ARTICLE

crossmark

Kaempferol ameliorated levodopa-induced dyskinesia in experimental rats: A role of brain monoamines, cFOS, FosB, Parkin, Pdyn, TH, and p-JNK

PEI QIN#, MIAO LIU#, XIN WANG, JIANHUA MA*

Geriatrics Department, Chengde Central Hospital, Chengde, 067000, China

* Corresponding Author: JIANHUA MA. Email: email

BIOCELL 2024, 48(3), 513-523. https://doi.org/10.32604/biocell.2023.045640

Abstract

Background: L-dopa (Levodopa) is well known for managing PD (Parkinson’s disease); however, its prolonged use caused dyskinesia (LID). Due to the varied presentation of LID, effective treatment options are scarce. Flavonoids reported their neuroprotective activity by ameliorating acetylcholinesterase, monoamine oxidase, and neuroinflammation. Kaempferol is another flavonoid bearing these potentials. Aim: To evaluate neuroprotective activity of kaempferol in dyskinetic rats. Methods: PD was developed in Sprague-Dawley rats by injecting combination of L-ascorbic acid (10 µL) + 6-OHDA (12 µg) in medial forebrain bundle to induce neuronal damage in substantial nigra (SNr). LID was induced by administrating combination of L-dopa (20 mg/kg) + benserazide HCl (5 mg/kg) for 42 days. Rats were concomitantly treated with amantadine (40 mg/kg) or kaempferol (25, 50, and 100 mg/kg, p.o.). Results: Kaempferol (50 and 100 mg/kg) markedly (p < 0.05) inhibited LID-induced abnormal involuntary movements (AIMs) and alternation in motor function. Kaempferol administration considerably (p < 0.05) inhibited reduced mitochondrial complex activities, serotonin and dopamine levels, Bcl-2, and Tyrosine hydroxylase protein expressions in SNr. Additionally, kaempferol considerably (p < 0.05) attenuated increased cFOS, FosB, Parkin, and Pdyn mRNAs expressions, Bax, cleaved caspase-3, caspase-3, and pJNK proteins levels; DOPAC and 5-HIAA levels in SNr. A positive correlation was reported between cFOS, FosB, Parkin, Pdyn, apoptosis, and TH with AIMs. Conclusion: Kaempferol effectively attenuated L-dopa-induced AIMs and dyskinesia via amelioration of alterations in cFOS, FosB, Parkin, Pdyn, Tyrosine hydroxylase, and apoptosis in the brain SNr.

Graphical Abstract

Kaempferol ameliorated levodopa-induced dyskinesia in experimental rats: A role of brain monoamines, cFOS, FosB, Parkin, Pdyn, TH, and p-JNK

Keywords


Cite This Article

APA Style
QIN, P., LIU, M., WANG, X., MA, J. (2024). Kaempferol ameliorated levodopa-induced dyskinesia in experimental rats: A role of brain monoamines, cfos, fosb, parkin, pdyn, TH, and p-jnk. BIOCELL, 48(3), 513-523. https://doi.org/10.32604/biocell.2023.045640
Vancouver Style
QIN P, LIU M, WANG X, MA J. Kaempferol ameliorated levodopa-induced dyskinesia in experimental rats: A role of brain monoamines, cfos, fosb, parkin, pdyn, TH, and p-jnk. BIOCELL . 2024;48(3):513-523 https://doi.org/10.32604/biocell.2023.045640
IEEE Style
P. QIN, M. LIU, X. WANG, and J. MA "Kaempferol ameliorated levodopa-induced dyskinesia in experimental rats: A role of brain monoamines, cFOS, FosB, Parkin, Pdyn, TH, and p-JNK," BIOCELL , vol. 48, no. 3, pp. 513-523. 2024. https://doi.org/10.32604/biocell.2023.045640



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 577

    View

  • 203

    Download

  • 0

    Like

Share Link